State Street Corp Vaxart, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Vaxart, Inc. stock. As of the latest transaction made, State Street Corp holds 851,119 shares of VXRT stock, worth $323,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
851,119
Previous 790,245
7.7%
Holding current value
$323,425
Previous $324,000
18.21%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding VXRT
# of Institutions
105Shares Held
23.1MCall Options Held
50.3KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.96 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$884,0200.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$674,2510.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$670,2750.0% of portfolio
-
Ubs Group Ag826KShares$313,7880.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $48.1M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...